Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $5.46 +1.30%
EPS Growth %: -8.3%
Financial Fact:
Net loss: -1.19M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -8.3%
Financial Fact:
Net loss: -1.19M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- FactSet acquires BCC Group to expand real-time market data platform
- CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
